• FirefoxTry Yahoo Finance on Firefox »
  •  Dow down 0.29% Nasdaq up 0.19%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow down 0.29% Nasdaq up 0.19%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
    No such ticker symbol: GEICOTry Symbol Lookup
    Mar 24 3.55 +0.05 +1.43% 3.42 3.55 26,651 226,877 84.31M Sparkline Chart Chart, News, Stats, Board
    No such ticker symbol: INSURANCETry Symbol Lookup
    No such ticker symbol: QUOTETry Symbol Lookup
    No such ticker symbol: GETTry Symbol Lookup
    No such ticker symbol: ORCCTry Symbol Lookup
    {"s" : "life","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Wednesday March 22, 2017
    ATYR PHARMA INC Financials EDGAR Online Financials01:04pm EDT
    Thursday March 16, 2017
    Atyr Pharma reports 4Q loss AP04:46pm EDT
    ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online04:12pm EDT
    Wednesday March 15, 2017
    aTyr Pharma Announces Issuance of US Patent That Extends Patent Protection of Physiocrines Derived From 20 out of 20 Human tRNA Synthetases PR Newswire06:00am EDT
    Friday March 3, 2017
    aTyr Pharma Receives EMA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy with Resolaris™ PR Newswire08:00am EST
    Wednesday March 1, 2017
    aTyr Pharma Rises 16% on Orphan Drug Status at Investopedia12:30pm EST
    aTyr Pharma to Present at Cowen and Company 37th Annual Health Care Conference PR Newswire08:00am EST
    Tuesday February 28, 2017
    aTyr Pharma Receives U.S. FDA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy with Resolaris™ PR Newswire08:00am EST
    Wednesday February 22, 2017
    High court ruling limits international reach of patent laws AP12:49pm EST
    Thursday January 19, 2017
    Atyr Pharma Stock Spikes 33% on FDA Updates at Investopedia12:00pm EST
    Wednesday January 18, 2017
    FDA Grants Fast Track Designation for aTyr's Resolaris™ to Treat Limb Girdle Muscular Dystrophy 2B and Removes Partial Clinical Hold for Resolaris PR Newswire08:00am EST
    Monday January 9, 2017
    ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online09:03am EST
    Wednesday January 4, 2017
    Roberts recuses from patent case after discovering conflict AP06:05pm EST
    Wednesday December 21, 2016
    Atyr Pharma Inc (LIFE) CEO and Director John Mendlein Bought $151,800 of Shares Gurufocus01:15pm EST
    Friday December 16, 2016
    Does aTyr Pharma Inc (LIFE) Stack Up Against Its Peers? at Insider Monkey10:07pm EST
    Tuesday December 13, 2016
    aTyr Pharma Drops on Clinical Update 24/7 Wall St.10:45am EST
    ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Other Events EDGAR Online07:02am EST
    aTyr Pharma Reports Promising Signals of Clinical Activity in Multiple Rare Genetically Distinct Myopathies with Resolaris™ in Exploratory Trials PR Newswire07:00am EST
    Friday December 9, 2016
    aTyr Pharma to Present at the BMO Prescriptions for Success Healthcare Conference PR Newswire09:00am EST
    Monday December 5, 2016
    aTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q3, 2016 By the Numbers : December 5, 2016 at Capital Cube11:39am EST
    Monday November 21, 2016
    ATYR PHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive EDGAR Online08:01am EST
    aTyr Pharma Enters into $20 Million Credit Facility PR Newswire08:00am EST